AF
CORT icon

Allworth Financial’s Corcept Therapeutics CORT Stock Holding History

Allworth Financial’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$338K Buy
3,892
+2,342
+151% +$141K ﹤0.01% 1193
2026
Q1 		$62.5K Sell
1,550
-8,783
-85% -$328K ﹤0.01% 2159
2025
Q4 		$360K Buy
10,333
+1,237
+14% +$97.2K ﹤0.01% 1079
2025
Q3 		$756K Sell
9,096
-222
-2% -$16.1K ﹤0.01% 744
2025
Q2 		$684K Buy
9,318
+9,267
+18,171% +$672K ﹤0.01% 745
2025
Q1 		$3.66K Buy
51
+30
+143% +$1.83K ﹤0.01% 2937
2024
Q4 		$1.24K Hold
21
– – ﹤0.01% 3333
2024
Q3 		$972 Buy
21
+7
+50% +$249 ﹤0.01% 3230
2024
Q2 		$475 Hold
14
– – ﹤0.01% 3384
2024
Q1 		$353 Sell
14
-10
-42% -$236 ﹤0.01% 3371
2023
Q4 		$780 Sell
24
-990
-98% -$27.2K ﹤0.01% 3035
2023
Q3 		$27.6K Sell
1,014
-37
-4% -$1.07K ﹤0.01% 1344
2023
Q2 		$23.4K Hold
1,051
– – ﹤0.01% 1445
2023
Q1 		$22.8K Buy
1,051
+51
+5% +$1.12K ﹤0.01% 1385
2022
Q4 		$20.3K Sell
1,000
-27
-3% -$677 ﹤0.01% 1361
2022
Q3 		$26K Buy
1,027
+27
+3% +$723 ﹤0.01% 1193
2022
Q2 		$24K Buy
1,000
+991
+11,011% +$21.6K ﹤0.01% 1164
2022
Q1 		$0 Sell
9
-382
-98% -$8.13K ﹤0.01% 2155
2021
Q4 		$8K Buy
+391
New +$7.93K ﹤0.01% 1458

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allworth Financial's CORT Position: Q2 2026 in Review

Allworth Financial increased its Corcept Therapeutics (CORT) stake by 151% in Q2 2026, buying an estimated $141K and bringing the position to 3,892 shares worth $338K. The position accounts for ﹤0.01% of the portfolio, ranked #1193.

Allworth Financial first reported a position in CORT in Q4 2021 and has held it in 19 quarters since. The position peaked at $756K in Q3 2025. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Allworth Financial held 3,892 shares of Corcept Therapeutics worth $338K as of Q2 2026.
  • Allworth Financial bought 2,342 Corcept Therapeutics shares in Q2 2026, an estimated $141K.
  • Corcept Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #1193 holding.
  • Allworth Financial first reported a position in Corcept Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • Allworth Financial's Corcept Therapeutics position peaked at $756K in Q3 2025.
  • 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.